Turning the spotlight on the oligosaccharide chain of GM1 ganglioside.
Drug development
GM1 oligosaccharide
Neurodegeneration
Neurodifferentiation
Neuroprotection
Parkinson’s disease
Journal
Glycoconjugate journal
ISSN: 1573-4986
Titre abrégé: Glycoconj J
Pays: United States
ID NLM: 8603310
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
05
12
2020
accepted:
29
01
2021
revised:
23
01
2021
pubmed:
24
2
2021
medline:
29
1
2022
entrez:
23
2
2021
Statut:
ppublish
Résumé
It is well over a century that glycosphingolipids are matter of interest in different fields of research. The hydrophilic oligosaccharide and the lipid moiety, the ceramide, both or separately have been considered in different moments as the crucial portion of the molecule, responsible for the role played by the glycosphingolipids associated to the plasma-membranes or to any other subcellular fraction. Glycosphingolipids are a family of compounds characterized by thousands of structures differing in both the oligosaccharide and the ceramide moieties, but among them, the nervous system monosialylated glycosphingolipid GM1, belonging to the group of gangliosides, has gained particular attention by a multitude of Scientists. In recent years, a series of studies have been conducted on the functional roles played by the hydrophilic part of GM1, its oligosaccharide, that we have named "OligoGM1". These studies allowed to shed new light on the mechanisms underlying the properties of GM1 defining the role of the OligoGM1 in determining precise interactions with membrane proteins instrumental for the neuronal functions, leaving to the ceramide the role of correctly positioning the GM1 in the membrane crucial for the oligosaccharide-protein interactions. In this review we aim to report the recent studies on the cascade of events modulated by OligoGM1, as the bioactive portion of GM1, to support neuronal differentiation and trophism together with preclinical studies on its potential to modify the progression of Parkinson's disease.
Identifiants
pubmed: 33620588
doi: 10.1007/s10719-021-09974-y
pii: 10.1007/s10719-021-09974-y
pmc: PMC7917043
doi:
Substances chimiques
Oligosaccharides
0
G(M1) Ganglioside
37758-47-7
asialo GM1 ganglioside
71012-19-6
Receptor, trkA
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-117Références
Neurol Neurochir Pol. 1993 Jan-Feb;27(1):31-8
pubmed: 8502357
Sci Rep. 2019 Dec 18;9(1):19330
pubmed: 31852959
Trends Neurosci. 1989 Nov;12(11):425-32
pubmed: 2479143
Mol Neurobiol. 2010 Jun;41(2-3):314-40
pubmed: 20127207
Biochim Biophys Acta. 1973 Jan 19;296(1):160-70
pubmed: 4693502
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5087-91
pubmed: 7539142
Exp Neurol. 2020 Jul;329:113284
pubmed: 32165255
J Biotechnol. 2008 Apr 30;134(3-4):261-5
pubmed: 18378033
Mol Neurobiol. 2016 Apr;53(3):1824-1842
pubmed: 25762012
J Lipid Res. 1984 Nov;25(11):1233-45
pubmed: 6520543
J Neurocytol. 1998 Jan;27(1):1-14
pubmed: 9530995
Biochemistry. 2007 Feb 20;46(7):1868-77
pubmed: 17253773
J Neurochem. 1988 Jul;51(1):277-82
pubmed: 3379408
J Neurosci. 2014 Feb 12;34(7):2477-92
pubmed: 24523539
J Neurochem. 1991 Jan;56(1):95-104
pubmed: 1987326
Biochemistry. 2015 Aug 18;54(32):4953-68
pubmed: 26214365
Trends Biochem Sci. 2015 Jul;40(7):407-18
pubmed: 26024958
Glycobiology. 2015 Dec;25(12):1323-4
pubmed: 26543186
Biochim Biophys Acta. 2000 Sep 18;1469(2):63-77
pubmed: 10998569
Neurotoxicol Teratol. 2002 Sep-Oct;24(5):599-605
pubmed: 12200191
Exp Neurol. 1991 Sep;113(3):301-5
pubmed: 1915720
PLoS One. 2014 Jul 30;9(7):e103727
pubmed: 25075858
Cell Signal. 2011 May;23(5):753-62
pubmed: 20946954
Methods Mol Biol. 2018;1804:97-141
pubmed: 29926406
Glycoconj J. 2020 Dec;37(6):713-727
pubmed: 33201378
J Lipid Res. 2015 Jan;56(1):129-41
pubmed: 25418321
Chem Phys Lipids. 1970 Oct;5(1):6-43
pubmed: 4394487
Int J Mol Sci. 2020 Apr 19;21(8):
pubmed: 32325905
Front Neurol. 2019 Aug 06;10:859
pubmed: 31447771
J Neurol Sci. 2013 Jan 15;324(1-2):140-8
pubmed: 23199590
J Neurosci Res. 2012 Oct;90(10):1997-2008
pubmed: 22714832
Klin Oczna. 1992;94(2-3):57-8
pubmed: 1640682
J Neurochem. 1997 Jun;68(6):2348-55
pubmed: 9166727
J Neurosci. 2005 Nov 23;25(47):11014-22
pubmed: 16306414
Chem Phys Lipids. 1994 May 6;71(1):21-45
pubmed: 8039256
Adv Carbohydr Chem Biochem. 2019;76:113-148
pubmed: 30851743
Glycoconj J. 2020 Jun;37(3):293-306
pubmed: 32266604
Neurochem Int. 1989;15(4):455-65
pubmed: 20504520
Spine (Phila Pa 1976). 2001 Dec 15;26(24 Suppl):S99-100
pubmed: 11805615
Sci Rep. 2019 Jun 10;9(1):8362
pubmed: 31182727
Int J Mol Sci. 2020 Jan 29;21(3):
pubmed: 32013258
Eur J Biochem. 1970 Aug;15(2):287-92
pubmed: 5502663
Glycoconj J. 2004;21(8-9):461-70
pubmed: 15750787
J Neurochem. 2001 Feb;76(3):650-60
pubmed: 11158235
J Lipid Res. 1964 Apr;5:145-55
pubmed: 14174000
ACS Chem Neurosci. 2020 May 6;11(9):1245-1249
pubmed: 32324990
J Neurochem. 2007 Dec;103(6):2327-41
pubmed: 17883393
J Neurochem. 1993 Oct;61(4):1277-83
pubmed: 8376985
J Parkinsons Dis. 2011;1(1):19-33
pubmed: 23275799
Prog Mol Biol Transl Sci. 2018;156:435-454
pubmed: 29747823
Mol Neurobiol. 2019 Oct;56(10):6673-6702
pubmed: 30911934
Glycobiology. 1996 Jul;6(5):479-87
pubmed: 8877367
Adv Exp Med Biol. 1980;125:11
pubmed: 7361610
J Neurochem. 2011 Mar;116(5):714-20
pubmed: 21214576
Adv Exp Med Biol. 1980;125:533-44
pubmed: 6244726
Curr Med Res Opin. 1990;12(3):169-76
pubmed: 2272191
Neurochem Res. 2014 Nov;39(11):2262-75
pubmed: 25216715
Prog Lipid Res. 2010 Oct;49(4):429-37
pubmed: 20553968
Int J Mol Sci. 2019 Nov 06;20(22):
pubmed: 31698745
Annu Rev Biochem. 2003;72:609-42
pubmed: 12676795
Z Naturforsch B. 1963 Jul;18:541-3
pubmed: 14048646
J Biol Chem. 2014 Aug 29;289(35):24488-98
pubmed: 25037226
Chem Phys Lipids. 1992 Jan-Feb;60(3):247-52
pubmed: 1505063
J Neurobiol. 1982 Mar;13(2):95-106
pubmed: 7062024
Neurotox Res. 2002 May;4(3):225-34
pubmed: 12829403
Prog Brain Res. 1994;101:391-404
pubmed: 8029467
Glycoconj J. 2012 Dec;29(8-9):585-97
pubmed: 22592846
J Neurosci Res. 1992 Feb;31(2):245-53
pubmed: 1573675
Anal Chem. 2016 Aug 2;88(15):7844-52
pubmed: 27376483
J Supramol Struct. 1978;8(1):1-17
pubmed: 366282
Glycoconj J. 2004;20(1):11-23
pubmed: 14973366
Adv Biol Regul. 2018 Dec;70:51-64
pubmed: 30287225
Adv Drug Deliv Rev. 1999 Apr 5;36(2-3):165-178
pubmed: 10837714
Methods Mol Biol. 2018;1804:19-55
pubmed: 29926403
J Biol Chem. 1995 Feb 17;270(7):3074-80
pubmed: 7852388
Neurochem Res. 2011 Sep;36(9):1706-14
pubmed: 21399908
Trends Biochem Sci. 2015 Jul;40(7):397-406
pubmed: 25941169
J Neurol Sci. 2010 May 15;292(1-2):45-51
pubmed: 20206941
Angew Chem Int Ed Engl. 1968 Feb;7(2):87-96
pubmed: 4968413
J Neurol Sci. 2015 Sep 15;356(1-2):118-23
pubmed: 26099170
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10829-34
pubmed: 19541636
Cell Mol Life Sci. 2005 Oct;62(19-20):2283-94
pubmed: 16158191
Glycobiology. 2002 Apr;12(4):235-40
pubmed: 12042246
J Neurosci. 2001 Nov 1;21(21):8387-95
pubmed: 11606627
FEBS Lett. 2019 Nov;593(22):3173-3189
pubmed: 31432511
Nat Neurosci. 2005 May;8(5):606-15
pubmed: 15834419
PLoS One. 2015 Dec 02;10(12):e0143351
pubmed: 26629687
J Neurosci. 2007 Jul 11;27(28):7447-58
pubmed: 17626205
Glycoconj J. 2020 Jun;37(3):329-343
pubmed: 32198666
Biochim Biophys Acta. 1982 Jun 14;688(2):333-40
pubmed: 7104327
J Neurochem. 2019 Apr;149(2):231-241
pubmed: 30776097
Chembiochem. 2003 May 9;4(5):406-12
pubmed: 12740812
Jpn J Exp Med. 1982 Dec;52(6):275-86
pubmed: 6133019
Biochem J. 1982 Jun 1;203(3):735-42
pubmed: 7115311
PLoS One. 2018 Jun 14;13(6):e0199189
pubmed: 29902255
Eur J Biochem. 1998 Oct 15;257(2):293-8
pubmed: 9826173
Adv Exp Med Biol. 1980;125:263-81
pubmed: 7361616
J Neurochem. 1984 Feb;42(2):299-305
pubmed: 6693871
Chem Phys Lipids. 1980 Apr;26(3):225-38
pubmed: 7371117
Int J Mol Sci. 2020 Jun 24;21(12):
pubmed: 32599772
J Neurochem. 1994 Nov;63(5):1802-11
pubmed: 7931336
J Neurochem. 2017 Dec;143(6):645-659
pubmed: 28796418